The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces

British Journal of Haematology

Volumn 120, Issue 2, 2003, Pages 315-324

  Paredes, Nethnapha ^a   Xu, Ling ^a   Berry, Leslie R ^a   Chan, Anthony K C ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

Cancer; Chemotherapy; Hypercoagulable state; Thrombin generation; Tissue factor

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTINEOPLASTIC AGENT; ANTITHROMBIN; ASPARAGINASE; BLOOD CLOTTING FACTOR 7; DOXORUBICIN; MESSENGER RNA; METHOTREXATE; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TRANSACTIVATOR PROTEIN; VINCRISTINE;

ARTICLE; CANCER PATIENT; CELL SURFACE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOEMBOLISM;

ALPHA-MACROGLOBULINS; ANTINEOPLASTIC AGENTS; ANTITHROMBINS; CELL MEMBRANE; DOXORUBICIN; ETOPOSIDE; HUMANS; METHOTREXATE; PROTHROMBIN; THROMBIN; THROMBOPLASTIN; THROMBOSIS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VINCRISTINE;

EID: 0037272659     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.03971.x     Document Type: Article

References (61)

1. Andrew, M., David, M., Adams, M., Ali, K., Anderson, R., Barnard, D., Berstein, M., Brisson, L., Cairney, B., DeSai, D., Grant, R., Israels, S., Jardine, L., Luke, B., Massicotte, P. & Silva, M. (1994a) Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood, 83, 1251-1257.
2. Andrew, M., Brooker, L. & Mitchell, L. (1994b) Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukemia. Blood Coagulation and Fibrinolysis, 5, S24-S36.
3. Asakura, H., Kamikubo, Y., Goto, A., Shiratori, Y., Yamazaki, M., Jokaji, H., Saito, M., Uotani, C., Kumabashiri, I., Morishita, E., Aoshima, K., Nakamura, S. & Matsuda, T. (1995) Role of tissue factor in disseminated intravascular coagulation. Thrombosis Research, 80, 217-224.
4. Avramis, V.I., Wiersma, S., Krailo, M.D., Ramilo-Torno, L.V., Sharp, A., Lin-Mares, W., Kowck, R., Reaman, G.H. & Sato, J.K. (1998) Pharmacokinetic and pharmacodynamic studies of fludarabine and cytosine arabinoside administered as loading boluses followed by continuous infusions after a phase I/II study in pediatric patients with relapsed leukemias. The Children's Cancer Group. Clinical Cancer Research. 4, 45-52.
5. Bastida, E., Ordinas, A., Escolar, G. & Jamieson, G.A. (1984) Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombo-genesis. Blood, 64, 177-184.
6. Berry, L., Andrew, M., Post, M., Ofosu, F. & O'Brodovich, H. (1991) A549 lung epithelial cell line synthesize anticoagulant molecules on the cell surface, matrix, and in conditioned media. American Journal of Respiratory Cell Molecular Biology. 4, 338-346.
7. Bertomeu, M.C., Gallo, S., Lauri, D., Levine, M.N., Orr, F.W. & Buchanan, M.R. (1990) Chemotherapy enhances endothelial cell reactivity to platelets. Clinical Experimental Methods, 8, 511-518.
8. Bona, R.D. (1999) Thrombotic complications of central venous catheters in cancer patients. Seminars in Thrombosis and Hemostasis, 25, 147-155.
9. Callander, N.S., Varki, N. & Rao, L.V.M. (1992) Immuno-histochemical identification of tissue factor in solid tumors. Cancer, 70, 1194-1201.
10. Constantini, V., De Monte, P., Cazzato, A.O., Stabile, A.M., Deveglia, R., Frezzato, E. & Paolucci, M.C. (1998) Systemic thrombin generation in cancer patients is correlated with extrinsic pathway activation. Blood Coagulation and Fibrinolysis, 9, 79-84.
11. Contrino, J., Hair, G., Kreutzer, D.L. & Rickles, F.R. (1996) In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Medicine, 2, 209-215.
12. Downing, M.R., Bloom, J.W. & Mann, K.G. (1978) Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry, 17, 2649-2653.
13. Drake, T.A., Morrissey, J.H. & Edgington, T.S. (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. American Journal of Pathology, 134, 1087-1097.
14. Dukic, S.F., Heurtaux, T., Kaltenbach, M.L., Hoizey, G., Lallemand, A. & Vistelle, R. (2000) Influence of schedule of administration on methotrexate penetration in brain tumours. European Journal of Cancer, 36, 1578-1584.
15. Dvorak, H.F. (1987) Thrombosis and cancer. Human Pathology, 18, 275-284.
16. Edwards, R.L., Rickles, F.R. & Cronlund, M. (1981) Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. Journal of Laboratory and Clinical Medicine. 98, 917-928.
17. Edwards, R.L., Klaus, M., Matthews, E., McCullen, C., Bona, R.D. & Rickles, F.R. (1990) Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels. American Journal of Medicine, 89, 25-28.
18. Fischer, E.G., Ruf, W. & Mueller, B.M. (1995) Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Research, 55, 1629-1632.
19. Francis, J.L., Biggerstaff, J. & Amirkhosravi, A. (1998) Hemostasis and malignancy. Seminars in Thrombosis and Hemostasis, 24, 93-109.
20. Gabazza, E.C., Taguchi, O., Yamakami, T., Machishi, M., Ibata, H., Suzuki, S. & Shima, T. (1994) Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer. European Journal of Cancer, 30A, 1276-1281.
21. Goodnough, L.T., Saito, H., Manni, A., Jones, P.K. & Pearson, O.H. (1984) Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. Cancer, 54, 1264-1268.
22. Gouin-Thibault, I. & Samama, M.M. (1999) Laboratory diagnosis of the thrombophilic state in cancer patients. Seminars in Thrombosis and Hemostasis, 25, 167-172.
23. Kakkar, A.K., DeRuvo, N., Chinswangwatanakul, V., Tebbutt, S. & Willlamson, R.C.N. (1995a) Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet, 346, 1004-1005.
24. Kakkar, A.K., Lemoine, N.R., Scully, M.F., Tebbutt, S. & Williamson, R.C.N. (1995b) Tissue factor expression correlates with histological grade in human pancreatic cancer. British Journal of Surgery, 82, 1101-1104.
25. Kakkar, A.K. & Williamson, R.C.N. (1999) Prevention of venous thromboembolism in cancer patients. Seminars in Thrombosis and Hemostasis, 25, 239-243.
26. Kim, Y.G., Cho, M.K., Kwon, J.W., Kim, S.G. & Lee, M.G. (2000) Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition. Research Communications in Molecular Pathology and Pharmacology, 107, 361-376.
27. Koomagi, R. & Volm, M. (1998) Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohisto-chemistry: correlation between tissue factor and angiogenesis. International Journal of Cancer, 79, 19-22.
28. Krishna, R., Webb, M.S., St Onge, G. & Mayer, L.D. (2001) Liposomal and non-liposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. Journal of Pharmacology and Experimental Therapeutics, 298, 1206-1212.
29. Kubota, T., Andoh, K., Sadakata, H., Tanaka, H. & Kobayashi, N. (1991) Tissue factor released from leukemic cells. Thrombosis and Haemostasis, 65, 59-63.
30. Lee, A.Y.Y. & Levine, M.N. (1999) The thrombophilic state induced by therapeutic agents in the cancer patient. Seminars in Thrombosis and Hemostasis, 25, 137-145.
31. Levine, M.N. (1997) Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thrombosis and Haemostasis, 78, 133-136.
32. Levine, M.N. & Lee, A.Y.Y. (1999) Treatment of venous throm-boembolism in cancer patients. Seminars in Thrombosis and Hemostasis, 25, 245-249.
33. Levine, M.N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M.D., Hryniuk, W. & De Pauw, S. (1988) The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. New England Journal of Medicine, 318, 404-407.
34. Lopez-Pedrera, C., Jardi, M., Ingles-Esteve, J., Munoz-Canoves, P., Dorado, G., Velasco, F. & Felez, J. (1997) Characterization of tissue factor expression on the human endothelial cell line ECV304. American Journal of Hematology, 56, 71-78.
35. Lorenzet, R., Peri, G., Locati, D., Allavena, P., Colucci, M., Semeraro, N., Mantovani, A. & Donati, M.B. (1983) Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood, 62, 271-273.
36. Mendelsohn, M.E., Abramson, D.H., Madden, T., Tong, W., Tran, H.T. & Dunkel, I.J. (1998) Intraocular concentrations of chemotherapeutic agents after systemic or local administration. Archives of Ophthalmology, 116, 1209-1212.
37. Mitchell, L., Hoogendoorn, H., Giles, A., Vegh, P. & Andrew, M. (1994a) Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L-asparaginase-induced antithrombin III deficiency. Blood, 83, 386-391.
38. Mitchell, L.G., Halton, J.M., Vegh, P.A., Barr, R.D., Venneri, T., Pai, M. & Andrew, M.E. (1994b) Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. American Journal of Pediatric Hematology and Oncology, 16, 120-126.
39. Monreal, M., Alastrue, A., Rull, M., Mira, X., Muxart, J., Rosell, R. & Abad, A. (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low molecular weight heparin (Fragmin). Thrombosis and Haemostasis, 75, 251-253.
40. Nicholson, G.L. & Custead, S.E. (1985) Effects of chemotherapeutic drugs on platelet and metastatic tumour cell - endothelial cell interactions as a model for assessing vascular integrity. Cancer Research, 45, 331-336.
41. Nishibe, T., Parry, G., Ishida, A., Aziz, S., Murray, J., Patel, Y., Rahman, S., Strand, K., Saito, K., Saito, Y., Hammond, W.P., Savidge, G.F., Mackman, N. & Wijelath, E.S. (2001) Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation. Blood, 97, 692-699.
42. Nowak-Gottl, U., Kuhn, N., Wolff, J.E., Boos, J., Kehrel, B., Rath, B. & Jurgens, H. (1996) Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children. European Journal of Haematology, 56, 35-38.
43. O'Brodovich, H., Berry, L., D'Costa, M., Burrows, R. & Andrew, M. (1991) The influence of fetal pulmonary epithelium on thrombin activity. American Journal of Physiology (Lung Cellular and Molecular Physiology), 5, L26 2-L270.
44. Piccioli, A., Prandoni, P., Ewert, R. & Goldhaber, S.Z. (1996) Cancer and venous thromboembollsm. American Heart Journal, 132, 850-855.
45. Priest, J.R., Ramsay, N.K.C., Steinherz, P.G., Tubergen, D.G., Cairo, M.S., Sitarz, A.L., Bishop, A.J., White, L., Trigg, M.E., Levitt, C.J., Cich, J.A. & Coccia, P.F. (1982) A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia. Journal of Pediatrics, 100, 984-989.
46. Rao, L.V. (1992) Tissue factor as a tumor procoagulant. Cancer Metastasis Reviews, 11, 249-266.
47. Ruf, W. & Edgington, T.S. (1994) Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB Journal, 8, 385-390.
48. Rao, L.V. & Pendurthi, U.R. (1998) Tissue factor on cells. Blood Coagulation and Fibrinolysis, 9, S27-S35.
49. Seto, S., Onodera, H., Kaido, T., Yoshikawa, A., Ishigami, S., Arii, S. & Imamura, M. (2000) Tissue factor expression in human colorectal carcinoma. Correlation with hepatic metastasis and impact on prognosis. Cancer, 88, 295-301.
50. Shigemori, C., Wada, H., Matsumoto, K., Shiku, H., Nakamura, S. & Suzuki, H. (1998) Tissue factor expression and metastatic potential of colorectal cancer. Thrombosis Haemostasis, 80, 894-898.
51. Silberberg, J.M., Gordon, S. & Zucker, S. (1989) Identification of tissue factor in two human pancreatic cancer cell lines. Cancer Research, 49, 5447.
52. Steinherz, P.G., Miller, L.P., Ghavimi, F., Allen, J.C. & Miller, D.R. (1981) Dural sinus thrombosis in children with acute lymphoblastic leukemia. Journal of the American Medical Association, 246, 2837-2839.
53. Sturm, U., Luther, T., Albrecht, S., Flossel, C., Grossmann, H. & Muller, M. (1992) Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Virchows Archive of Pathology Anatomy and Histopathology, 421, 79-86.
54. Takahashi, H., Sato, N. & Shibata, A. (1995) Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behaviour with plasma tissue factor. Thrombosis Research, 80, 339-348.
55. von Tempelhoff, G.F., Dietrich, M., Hommel, G. & Heilmann, L. (1996) Blood coagulation during adjuvant epirubicin/cyclophophamide chemotherapy in patients with primary operable breast cancer. Journal of Clinical Oncology, 14, 2560-2568.
56. Towbin, H. & Gordon, J. (1984) Immunoblotting and dot immunobinding: current status and outlook. Journal of Immunological Methods, 72, 313-340.
57. Trousseau, A. (1865) Phlegmasia alba dolens. Clinique Medicale de l'Hotel Dieu de Paris, pp. 654-712. Balliere, Paris.
58. Wada, H., Nakase, T., Nakaya, R., Minamikawa, K., Wakita, Y., Kaneko, T., Ohiwa, M., Deguchi, K. & Shirakawa, S. (1994) Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. American Journal of Hematology, 45, 232-236.
59. Weiss, R.B., Tormey, D.C., Holland, J.F. & Weinberg, V.E. (1981) Venous thrombosis during multimodal treatment of primary breast carcimoma. Cancer Treatment Report, 65, 677-679.
60. Wojtukiewicz, M.Z., Zacharski, L.R., Rucinska, M., Zimnoch, L., Jaromin, J., Rozanska-Kudelska, M., Kisiel, W. & Kudryk, B. (1999) Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma. Thrombosis and Haemostasis, 82, 1659-1662.
61. Xu, L., Delorme, M., Berry, L., Ofosu, F., Mitchell, L., Paes, B. & Andrew, M. (1995) Alpha-2-macroglobulin remains as important as ATIII for thrombin regulation in cord plasma in the presence of endothelial cell surfaces. Pediatric Research, 37, 1-6.